Study identifier:D1699R00045
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
PHenotype-based RApid SEquencing of guideline-directed medical therapy for Heart Failure with reduced ejection fraction (PHRASE-HF): A multicentre, prospective, non-interventional study to examine outcomes of rapid in-hospital implementation of GDMT and its translation from discharge into routine care
Heart Disease, heart failure
N/A
No
-
All
438
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|